Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1 2Phase 2/3 1

Status

Recruiting 46Active not recruiting 26Completed 13Terminated 8Not yet recruiting 5Available 2Suspended 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Myeloid 5Other hematologic neoplasm 3

Conditions

Breast Neoplasms 355Neoplasms 252Carcinoma, Non-Small-Cell Lung 199Colorectal Neoplasms 181Lung Neoplasms 151Prostatic Neoplasms 150Carcinoma, Hepatocellular 127Leukemia, Myeloid, Acute 96Pancreatic Neoplasms 86Multiple Myeloma 82Neoplasm Metastasis 73Recurrence 72Uterine Cervical Neoplasms 68Rectal Neoplasms 68Ovarian Neoplasms 65Stomach Neoplasms 64Triple Negative Breast Neoplasms 59Squamous Cell Carcinoma of Head and Neck 57Brain Neoplasms 56Head and Neck Neoplasms 55Glioblastoma 55Precursor Cell Lymphoblastic Leukemia-Lymphoma 51Small Cell Lung Carcinoma 48Melanoma 45Endometrial Neoplasms 43Disease 43Esophageal Neoplasms 42Hematologic Neoplasms 41Glioma 41Colonic Neoplasms 41

Interventions

luspatercept 1Tacrolimus 1Resistance Training 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Not yet recruiting × Primary Myelofibrosis × 1 year × Clear all
NCT07539779 2026-04-20

Luspatercept in Preventing Poor Erythroid Engraftment for Hematological Malignancies With Moderate to Severe Myelofibrosis

Nanfang Hospital, Southern Medical University

Phase 2/3 Not yet recruiting
196 enrolled
MyeloidOther hematologic neoplasm

Hematologic Neoplasms, Primary Myelofibrosis

NCT07302776 2026-04-17

TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT

Stanford University

Phase 1 Not yet recruiting
50 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Primary Myelofibrosis

NCT07529951 2026-04-14

Study of ZE74-0282 for Patients With JAK2 V617F Positive Blood Cancers

Eilean Therapeutics

Phase 1 Not yet recruiting
60 enrolled
Myeloid

Polycythemia Vera, Primary Myelofibrosis

NCT07518940 2026-04-09

ENERGIA

University of Turin, Italy

Phase NA Not yet recruiting
25 enrolled
MyeloidOther hematologic neoplasm

Motor Activity, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Primary Myelofibrosis

NCT07349134 2026-01-20

WELL-MPN

Brigham and Women's Hospital

Phase NA Not yet recruiting
75 enrolled
Myeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡